Financial Statements — TME
Balance Sheet
(in billions CNY)| Metric | FY
2024 | FY
2023 | FY
2022 | FY
2021 | FY
2020 | FY
2019 |
|---|
| Cash & Equivalents | 13.16 | 13.57 | 9.56 | 6.59 | 11.13 | 15.43 |
| Inventory | 0.02 | 0.01 | 0.01 | 0.02 | 0.02 | 0.03 |
| Total Current Assets | 34.54 | 29.94 | 26.56 | 26.79 | 31.69 | 26.91 |
| Goodwill | 19.65 | 19.54 | 19.49 | 19.12 | 17.49 | 17.14 |
| Total Non-current Assets | 55.90 | 45.60 | 40.45 | 40.46 | 36.59 | 25.76 |
| Total Assets | 90.44 | 75.54 | 67.01 | 67.25 | 68.27 | 52.68 |
| Total Current Liabilities | 16.55 | 12.01 | 11.72 | 10.45 | 9.60 | 8.49 |
| Total Non-current Liabilities | 4.17 | 6.32 | 6.17 | 5.75 | 5.94 | 0.51 |
| Total Liabilities | 20.72 | 18.33 | 17.88 | 16.20 | 15.54 | 9.00 |
| Retained Earnings | 20.05 | 16.97 | 12.05 | 14.19 | 11.11 | 7.01 |
| Total Stockholder Equity | 69.73 | 57.20 | 49.13 | 51.06 | 52.73 | 43.68 |
Income Statement
(in billions CNY)| Metric | FY
2024 | FY
2023 | FY
2022 | FY
2021 | FY
2020 | FY
2019 |
|---|
| Total Revenue | 28.40 | 27.75 | 28.34 | 31.24 | 29.15 | 25.43 |
| Cost of Revenue* | 16.38 | 17.96 | 19.57 | 21.84 | 19.85 | 16.76 |
| Gross Profit | 12.03 | 9.80 | 8.77 | 9.40 | 9.30 | 8.67 |
| Research & Development | 2.28 | 2.53 | 2.58 | 2.34 | 1.67 | 1.16 |
| Selling, General & Admin | 3.81 | 4.12 | 4.41 | 4.01 | 3.10 | 2.70 |
| Total Operating Expenses | 4.68 | 5.02 | 5.56 | 6.69 | 5.58 | 4.74 |
| Operating Income | 8.71 | 6.06 | 4.44 | 3.80 | 4.71 | 4.62 |
| Pretax Income | 8.71 | 6.05 | 4.37 | 3.63 | 4.63 | 4.54 |
| Tax Provision | 1.60 | 0.83 | 0.53 | 0.42 | 0.46 | 0.56 |
| Net Income | 7.11 | 5.22 | 3.84 | 3.22 | 4.18 | 3.98 |
* Derived from reported values
Cash Flow Statement
(in billions CNY)| Metric | FY
2024 | FY
2023 | FY
2022 | FY
2021 | FY
2020 | FY
2019 |
|---|
| Operating Cash Flow | 10.28 | 7.34 | 7.48 | 5.24 | 4.89 | 6.20 |
| Investing Cash Flow | (6.82) | (1.86) | (1.45) | (6.00) | (14.21) | (8.10) |
| Financing Cash Flow | (3.83) | (1.54) | (3.42) | (3.71) | 5.29 | (0.03) |